
    
      The study is being conducted worldwide.

      It consists of 4 segments:

        -  Segment A: 7-day run-in (screening)

        -  Segment B: 12-week double blind treatment

        -  Segment C: 40-week open treatment extension

        -  Segment D: 2-week run-out period
    
  